Digital Sleep Programs for Preventing Perinatal Depression
(PRISM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores two online sleep programs to determine which better helps pregnant individuals with insomnia prevent depression around childbirth. Participants will either engage in digital cognitive behavioral therapy for insomnia (CBT-I) or learn about sleep hygiene (SHE) through online sessions. The study aims to understand whether improving sleep can reduce depression and how the initial severity of depression affects outcomes. Pregnant individuals between 14 to 28 weeks, who struggle with insomnia but do not have major depression or take antidepressants, might be suitable candidates. Participants need daily internet access to join the online sessions and complete surveys until their baby is one year old.
As an unphased trial, this study offers participants the chance to contribute to important research that could enhance mental health care for pregnant individuals.
Do I have to stop taking my current medications?
The trial requires that participants do not take or plan to take antidepressant medication. If you are on antidepressants, you would need to stop taking them to participate.
What prior data suggests that these digital sleep programs are safe for pregnant people?
Research has shown that digital cognitive behavioral therapy for insomnia (dCBT-I) is well-received by pregnant individuals. Studies have found that it improves sleep quality without causing significant side effects. In one study, participants experienced better sleep and fewer insomnia symptoms without major issues.
While less research exists for digital sleep hygiene education (SHE), similar programs have been safely used in various settings to improve sleep habits. These programs teach better sleep practices and are generally considered safe with no known negative effects.
Overall, both digital CBT-I and SHE are non-invasive and have been used in other studies without major safety concerns. Participants can expect these treatments to be safe and aimed at improving sleep and reducing the risk of depression during pregnancy.12345Why are researchers excited about this trial?
Researchers are excited about these digital sleep programs for preventing perinatal depression because they offer innovative, accessible approaches to mental health care. Digital cognitive behavioral therapy for insomnia (CBT-I) is unique because it leverages technology to provide structured, evidence-based therapy directly to users, helping them manage sleep issues without needing in-person sessions. Meanwhile, digital sleep hygiene education (SHE) serves as an active comparator, offering practical tips and strategies to improve sleep habits. These digital methods can be accessed anytime and anywhere, making them particularly appealing for new and expecting mothers who may have difficulty attending traditional therapy sessions.
What evidence suggests that this trial's treatments could be effective for preventing perinatal depression?
Research has shown that digital cognitive behavioral therapy for insomnia (CBT-I), one of the treatments in this trial, effectively reduces insomnia and depression symptoms in pregnant and new mothers. A review of several studies found that CBT-I improves sleep quality and lessens depression in these women. Another study discovered that using CBT-I during pregnancy helps with staying asleep, leading to better outcomes after childbirth.
Digital sleep hygiene education (SHE), another treatment option in this trial, also helps manage sleep issues. A review of research found that sleep programs like SHE can improve sleep for mothers, which might lower the risk of depression after childbirth. Technology-based methods, including SHE, have effectively reduced symptoms of depression and anxiety after childbirth. Both CBT-I and SHE aim to improve sleep and mental health, but CBT-I has shown stronger benefits in reducing depression symptoms.12367Who Is on the Research Team?
Jennifer N Felder, PhD
Principal Investigator
University of California, San Francisco
Are You a Good Fit for This Trial?
This trial is for pregnant individuals between 14-28 weeks gestation, aged 18 or older, who have insomnia and access to the internet. They must speak English but can't join if they work night shifts, have other sleep disorders or severe psychiatric conditions like bipolar disorder or active suicidality, are currently majorly depressed, or take antidepressants.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either digital cognitive behavioral therapy for insomnia (CBT-I) or digital sleep hygiene education (SHE) over six weekly online sessions
Follow-up
Participants complete surveys and interviews to monitor outcomes until 1 year postpartum
What Are the Treatments Tested in This Trial?
Interventions
- Digital CBT-I
- Digital SHE
Digital CBT-I is already approved in United States, European Union for the following indications:
- Insomnia during pregnancy
- Prevention of perinatal depression
- Insomnia during pregnancy
- Prevention of perinatal depression
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor
Stanford University
Collaborator